LUMIBIRD announced the opening of its new Indian subsidiary in Mumbai: Lumibird Medical India. This company aims to boost sales of Quantel Medical and Ellex products in India with a shared range of ultrasound platforms, ophthalmic lasers and equipment for the diagnosis and treatment of dry eye.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
12.5 EUR | +0.40% | -4.94% | +2.63% |
23/04 | Lumibird: over 7% growth in quarterly sales | CF |
13/03 | Lumibird: EBITDA improved by 10% in 2023 | CF |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.63% | 294M | |
+7.27% | 219B | |
+5.43% | 183B | |
+9.67% | 132B | |
+23.35% | 106B | |
-2.81% | 62.09B | |
+4.81% | 50.88B | |
+10.58% | 50.8B | |
-1.17% | 40.64B | |
+24.88% | 31.59B |
- Stock Market
- Equities
- LBIRD Stock
- News LUMIBIRD
- Lumibird Announces Opening of its New Indian Subsidiary in Mumbai: Lumibird Medical India